Sodium Phenylacetate and Sodium Benzoate (Oceanside Pharmaceuticals)
Welcome to the PulseAid listing for the Sodium Phenylacetate and Sodium Benzoate drug offered from Oceanside Pharmaceuticals. This Ammonium Ion Binding Activity [MoA],Nitrogen Binding Agent [EPC],Ammonium Ion Binding Activity [MoA],Nitrogen Binding Agent [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Oceanside Pharmaceuticals |
| NON-PROPRIETARY NAME: | sodium phenylacetate and sodium benzoate |
| SUBSTANCE NAME: | SODIUM PHENYLACETATE; SODIUM BENZOATE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Ammonium Ion Binding Activity [MoA],Nitrogen Binding Agent [EPC],Ammonium Ion Binding Activity [MoA],Nitrogen Binding Agent [EPC] |
| ROUTE: | INTRAVENOUS |
| DOSAGE FORM: | INJECTION, SOLUTION, CONCENTRATE |
| MARKETING CATEGORY NAME: | NDA AUTHORIZED GENERIC |
| START MARKETING DATE: | 2017-03-15 |
| END MARKETING DATE: | 0000-00-00 |
Sodium Phenylacetate and Sodium Benzoate HUMAN PRESCRIPTION DRUG Details:
| Item Description | Sodium Phenylacetate and Sodium Benzoate from Oceanside Pharmaceuticals |
| LABELER NAME: | Oceanside Pharmaceuticals |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 100; 100(mg/mL; mg/mL) |
| START MARKETING DATE: | 2017-03-15 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 68682-001_e556c1e8-8bde-493b-92c6-4e750ae7a0e0 |
| PRODUCT NDC: | 68682-001 |
| APPLICATION NUMBER: | NDA020645 |
Other SODIUM PHENYLACETATE; SODIUM BENZOATE Pharmaceutical Manufacturers / Labelers:
